Publications by authors named "S Rubler"

Cilazapril (C), an angiotensin-converting enzyme inhibitor with effective antihypertensive efficacy, was examined for its ability to alter exercise tolerance testing (ETT) and respiratory oxygen uptake in 33 patients with congestive heart failure (CHF). C was administered in capsules daily to patients with New York Heart Association Class II or Class III CHF for 12 weeks, in parallel double-blind treatment groups of 0 mg (n = 8), 0.5 mg (n = 8), 1.

View Article and Find Full Text PDF

Arm exercise with myocardial scintigraphy and oxygen consumption determinations was performed by 33 men with peripheral vascular disease, 40 to 74 years of age (group 2). None had evidence of coronary disease. Nineteen age-matched male control subjects (group 1) were also tested to determine the normal endurance and oxygen consumption during arm exercise in their age group and to compare the results with those obtained during a standard treadmill performance.

View Article and Find Full Text PDF

Sixty-eight men with diabetes mellitus (mean age 53 +/- 10 years) and no symptoms of cardiac dysfunction enrolled in a long-range study for detection of latent coronary artery disease. The testing included maximal treadmill stress with thallium-201 scintigraphy and echocardiography. Radionuclide angiography was available in 35 men (52%), and 24 (35%) had gated scanning with exercise.

View Article and Find Full Text PDF